Drugs with this side effect
- 1,25(OH)2D3
- 4-AP: 3%
- 4-PBA: common
- 5-ASA: postmarketing, 4% - 13%
- 5-aza-2'-deoxycytidine: 13.6% - 34.9%
- 5-azacytidine: very common, 0% - 50.3%
- 68Ga
- ACTH(1-39: 0%
- ALX 111
- AMD3100: common
- Abarelix: 14.8%
- Anidulafungin: 8.4% - 11.2%
- BCNU: 1% - 19.2%
- BPTI
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: very common, 17%
- Cancidas
- Cantril
- Carfilzomib: 0% - 20.9%
- Enfuvirtide
- FAMP
- FK463
- Fe(III: 0.5% - 3.2%
- Forteo: 5.4%
- Gd-DTPA
- Goserelin: 1-10% - 12%
- Histrelin
- ICI 182,780: 3.48% - 12.5%
- Implanon: postmarketing
- K779: 1% - 14%
- Kaluril
- L-Dmp
- LY146032: postmarketing, common, 6.2% - 12.1%
- Leuprorelin: 7% - 9%
- Lisinopril: 0.2% - 0.8%
- Lovaza
- Lu AA21004: 3% - 6%
- Madopar
- Meropenem anhydrous: 1.4% - 7%
- Mersyndol
- Metrodin: postmarketing, 0% - 2.7%
- N-methylscopolamine
- Nafarelin
- NuvaRing
- Octreotide: very common, 1% - 8.8%
- Oestrogen
- PCI-32765: 0% - 15%
- Photofrin: 1.16% - 24%
- Photofrin II: very common, 13%
- Prussian blue
- Revasc
- Romidepsin: 0.763% - 40.4%
- SOM230: 5% - 8.54%
- SU5416
- Sativex
- Signifor: 5% - 8.54%
- Stalevo 50
- Supremon: 1.19%
- TMC435
- Triptorelin: 1.7%
- UDCA: postmarketing, 9.68% - 26.4%
- VACV: 1% - 21%
- Vancocine
- Zyprexa Relprevv: common
- abiraterone: 0.4% - 0.6%
- acamprosate: frequent
- acarbose: postmarketing
- acebutolol: 0% - 7%
- acetaminophen: 6.7%
- acitretin: postmarketing
- acyclovir
- afatinib: 0% - 13%
- agomelatine
- alendronate: 0% - 3.1%
- alfuzosin: 1.06%
- aliskiren
- allopurinol
- alosetron: postmarketing, 70%
- alprazolam: 0.9% - 26.2%
- alvimopan
- amantadine: uncommon, common
- ambrisentan: common, 3.08% - 5.97%
- amiloride
- amiodarone
- amisulpride: common, 3% - 4%
- amitriptyline
- amlodipine
- amlodipine besylate
- amobarbital
- amoxapine: 12%
- amphetamine
- amphotericin B: 14.9% - 20.7%
- anagrelide: 1-5%
- anastrozole: 6.87% - 12.9%
- anthracycline: 0% - 18%
- apomorphine
- apraclonidine: postmarketing
- aprepitant: 2% - 18%
- argatroban: 1% - 8%
- aripiprazole: common, 3% - 13%
- arsenic
- arsenic trioxide
- articaine
- asenapine: 1.55% - 7%
- atazanavir
- atenolol
- atomoxetine: 0% - 10%
- atorvastatin: 0% - 2.5%
- atovaquone: 3%
- atropine
- auranofin
- avanafil
- axitinib: 1% - 20%
- azelastine
- azithromycin: postmarketing
- baclofen: common, 0% - 5.1%
- balsalazide: 1% - 1.16%
- belinostat: 1% - 23%
- benazepril
- benazeprilat
- bendamustine
- bendrofluazide
- benzonatate
- benztropine
- bepridil: 2.84%
- betaxolol
- bexarotene: common, 10%
- bezafibrate
- bicalutamide: 17% - 22%
- bisoprolol: postmarketing, common
- boceprevir: common
- bortezomib: 0% - 49.7%
- bosentan
- bromocriptine: postmarketing, common, 3% - 14%
- budesonide: 0.394% - 1.96%
- bupivacaine: 2.06% - 7%
- buprenorphine: 3% - 14.4%
- bupropion: 4% - 26%
- buspirone: frequent, 1%
- busulfan: 38%
- butabarbital
- butorphanol
- cabazitaxel: 1%
- cabergoline: 3.8% - 22.7%
- cabozantinib: 0% - 27%
- calcium
- calcium acetate
- canagliflozin: common, 1.8% - 2.3%
- candesartan cilexetil
- capecitabine: 1% - 18%
- captopril
- carbamazepine: uncommon, common, 5% - 10%
- carbidopa: 0.2% - 1.5%
- carbinoxamine
- carboplatin: 3% - 6%
- carnitine: 3%
- carvedilol
- cefaclor
- cefdinir
- cefditoren
- cefepime
- cefpodoxime
- ceftaroline: 2%
- ceftobiprole
- celecoxib
- cephem
- cerivastatin: 2.2%
- cetirizine
- cevimeline
- chlordiazepoxide
- chlorpheniramine
- chlorpromazine
- chlorthalidone: rare
- cidofovir
- cilazapril
- cimetidine: common, 1%
- cinacalcet: 10.3% - 17.6%
- ciprofloxacin: postmarketing
- citalopram: 1% - 8.4%
- cladribine: very common, 4% - 9%
- clarithromycin: common
- clemastine
- clindamycin: 2% - 2.35%
- clindamycin phosphate
- clobazam: 2% - 10%
- clofazimine
- clomiphene citrate
- clomipramine: very common, 22% - 47%
- clonazepam: 2%
- clonidine: 1% - 6%
- clopidogrel: postmarketing, uncommon
- clozapine: 10% - 25%
- codeine
- colesevelam: 6.5% - 11%
- colestimide: common
- colestipol
- colestyramine: common
- conivaptan: 3.3%
- copolymer 1
- crizotinib: 0% - 42%
- cyclizine
- cyclobenzaprine: 1% - 3%
- cyclophosphamide: postmarketing
- cyproheptadine
- cyproterone
- cyproterone acetate
- cysteamine
- cytarabine: 0% - 25%
- dabigatran etexilate
- dabrafenib: common, 0% - 22%
- dalteparin: 1.35% - 1.72%
- danazol
- dantrolene
- dapagliflozin: 1.9% - 2.2%
- darifenacin: 0.593% - 21.3%
- darunavir: 0.6% - 4.58%
- dasatinib: 0% - 14%
- deferasirox: common
- degarelix: 3% - 5%
- delamanid
- delavirdine
- deprenyl: frequent, 4%
- desipramine
- desmopressin: 1%
- desvenlafaxine: 9% - 14%
- dexmedetomidine: 6% - 6.1%
- dexrazoxane
- dextromethorphan
- dextrorphan
- diazepam
- dichlorphenamide
- diclofenac: very rare, 0% - 8%
- dicyclomine: postmarketing
- diethylpropion
- diflunisal
- dihydrocodeine: common
- diltiazem: 1% - 3.63%
- diphenhydramine
- disopyramide: 11%
- docetaxel: postmarketing, rare, 0% - 38%
- dolasetron: 28.6%
- domperidone
- donepezil: frequent, 4.1% - 5.1%
- dothiepin
- doxazosin: 1% - 1.3%
- doxepin: rare
- doxercalciferol: 3.3%
- doxorubicin: very common, 0% - 31%
- duloxetine: 2% - 15%
- efavirenz: postmarketing
- eletriptan: infrequent
- eliglustat: 0% - 4.72%
- entacapone: common, 6% - 6.3%
- eplerenone: common
- eprosartan
- eribulin: 1% - 25%
- erlotinib
- ertapenem: 0% - 4%
- eslicarbazepine
- eslicarbazepine acetate
- esmolol
- esomeprazole magnesium
- estazolam: frequent
- estradiol: postmarketing, 1.12% - 6.67%
- etidronate
- etodolac
- etoposide: 8%
- etoposide phosphate: 8%
- etoricoxib
- etravirine
- everolimus: common, very common, 0% - 42.9%
- exemestane: common, 0.8% - 8%
- exenatide: postmarketing, uncommon, 1.2% - 10.1%
- ezetimibe: postmarketing
- famciclovir: 1%
- famotidine: 1.2% - 2%
- febuxostat: uncommon
- felbamate: 2% - 12.9%
- felodipine
- fenofibrate: 0.533% - 3.27%
- fenofibric acid: 2.1% - 3.27%
- fenoldopam
- fenoprofen
- fentanyl: very rare, postmarketing, common, 0% - 26.3%
- ferumoxytol: postmarketing, 2.1%
- fesoterodine: 4.2% - 6%
- fidaxomicin: 1.2%
- flecainide: 1% - 4.4%
- flucloxacillin
- fluconazole
- fludarabine: 1% - 3%
- flunisolide
- fluoxetine: 4.2% - 6.9%
- fluphenazine
- fluphenazine decanoate
- flurazepam
- flurbiprofen
- flutamide
- fluvastatin: 0.8% - 3.3%
- fluvoxamine: common, frequent, 1% - 18%
- fondaparinux: rare, 1.8% - 10.5%
- formoterol
- fosaprepitant
- fosaprepitant dimeglumine: 7.6% - 8.5%
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril: uncommon
- fosinoprilat
- fosphenytoin: frequent
- frovatriptan: infrequent
- furosemide
- gabapentin: 0.8% - 19%
- gadobenate dimeglumine
- gadolinium
- gadoversetamide
- galantamine
- ganciclovir
- gatifloxacin
- gefitinib
- gemcitabine: common, 0% - 39%
- gemfibrozil: 1.4%
- gemifloxacin
- gliclazide: 1.2% - 1.6%
- glipizide
- glutamine: 0% - 11.1%
- glycopyrrolate: 35%
- gonadorelin: 0% - 2.54%
- granisetron: 3% - 19%
- guanfacine: postmarketing, 2% - 14%
- halofantrine
- haloperidol
- histamine
- hydralazine: frequent
- hydrochlorothiazide
- hydrocodone: 7.95% - 11%
- hydroflumethiazide
- hydromorphone: 7.46% - 30.9%
- hydroxybutyrate
- hydroxyurea: 1-5%
- ibandronate: 2.5% - 4.1%
- ibuprofen: 22%
- icodextrin
- ifosfamide: postmarketing, 1%
- imatinib: common, 0% - 16%
- imipramine: very common
- indapamide: 2%
- indinavir
- indomethacin: 4% - 6%
- insulin detemir
- iopromide
- iotrolan
- ioxilan
- ipratropium bromide: postmarketing, uncommon, 0% - 1.4%
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- irinotecan: 0.4% - 32.3%
- iron sucrose: 5.5%
- isocarboxazid
- isomannide
- isosorbide-5-mononitrate
- isradipine
- itraconazole: postmarketing, 0% - 3%
- ivabradine
- ivermectin: 0.9%
- ixabepilone: 0% - 16%
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- labetalol: 1.6%
- lacosamide
- lamivudine
- lamotrigine: 2% - 8.9%
- lanreotide
- lansoprazole: 1% - 5%
- lanthanum: postmarketing
- lanthanum carbonate: 6% - 14%
- lapatinib: common, very common
- lasofoxifene: common
- leflunomide
- lenalidomide: postmarketing, very common, 0.746% - 40.5%
- lercanidipine
- letrozole: common, 0.0251% - 11.3%
- leucovorin: 0% - 4%
- leuprorelin acetate: 1% - 11.5%
- levetiracetam: 3%
- levodopa/carbidopa: 0.2%
- levomepromazine
- levonorgestrel
- levosimendan
- linagliptin: uncommon
- linezolid: 2.1% - 2.2%
- liraglutide: postmarketing, 4.8% - 9.9%
- lisdexamfetamine dimesylate: postmarketing
- lomefloxacin
- lomitapide
- loperamide: postmarketing, 1.6% - 5.3%
- loratadine
- lorazepam
- lorcaserin: 5.82%
- lormetazepam
- losartan
- lovastatin: 2% - 3.5%
- loxapine
- mTHPC: very common
- maprotiline: 6%
- maraviroc: 3% - 6%
- mecamylamine
- meclofenamate
- medroxyprogesterone acetate: 0.2 - 1.0%
- mefenamic acid
- megestrol
- megestrol acetate
- meloxicam: 0% - 3.9%
- memantine: 3% - 5%
- meperidine
- meropenem: 1.4% - 7%
- mesna
- metformin: 2.87% - 5.02%
- methadone
- methamphetamine
- methsuximide
- methyclothiazide
- methyldopa
- methylphenidate: 1.4% - 1.5%
- methysergide
- metolazone
- metoprolol: postmarketing, rare, common
- metronidazole: 12%
- mexiletine: 4% - 11.6%
- mianserin
- midazolam
- mifepristone: 10%
- miglitol: postmarketing
- miglustat: 0% - 25%
- milnacipran: 9% - 16%
- minocycline
- mirabegron: 0.9% - 2.8%
- mirtazapine: 12.6% - 13%
- misoprostol: 1.1%
- mitoxantrone: 10% - 14%
- moclobemide
- modafinil: 1%
- moexiprilat
- molindone
- morphine: postmarketing, 9% - 12%
- moxifloxacin
- mycophenolate mofetil: 1.3% - 41.2%
- mycophenolic acid: 18.5% - 41.2%
- n-3 PUFA
- nabilone: postmarketing
- nabumetone: 4%
- nadolol
- naltrexone
- naproxen: postmarketing
- naratriptan: infrequent
- nefazodone
- nelarabine: 0% - 21%
- nicardipine
- nicorandil: uncommon
- nicotine
- nifedipine: 1% - 3.5%
- nilotinib: 0% - 12%
- nilutamide: 7.1%
- nitazoxanide
- nitrazepam
- nitrofurantoin
- nizatidine: 2.5%
- norfloxacin: postmarketing
- nortriptyline
- ofloxacin
- olanzapine: common, 4% - 14.5%
- olmesartan
- olodaterol
- omeprazole: common, 0% - 2.5%
- ondansetron: common, 0.382% - 9.09%
- orphenadrine
- oxaliplatin: very common, 1% - 31%
- oxaprozin
- oxcarbazepine: common, 0% - 6%
- oxybutynin: common, 0% - 15.1%
- oxycodone: 5% - 26%
- oxymorphone: 4% - 28%
- paclitaxel: very rare, postmarketing, 18%
- paliperidone: 4% - 5%
- palonosetron: 1.95% - 6.19%
- pamidronate: common, 0% - 36%
- pantoprazole: postmarketing, common
- papaverine
- parecoxib
- paricalcitol: 3% - 4.9%
- paroxetine: common, 1.1% - 13%
- pemetrexed: 0% - 44%
- pentamidine
- pentazocine
- pentobarbital
- pentosan polysulfate
- pentostatin
- pentoxifylline
- perampanel: 2% - 3%
- pergolide: frequent, 10.6%
- perindopril
- perindopril erbumine
- perphenazine
- phendimetrazine
- phenelzine
- phenobarbital
- phentermine
- phenylbutyric acid
- phenylpropanolamine
- phenytoin: frequent
- pilocarpine
- pimecrolimus: 0% - 3.7%
- pimozide: postmarketing, 4%
- pinaverium bromide: 0.4%
- pindolol
- piperacillin: uncommon
- pirfenidone
- piroxicam: 3.8%
- pitavastatin: 1.5% - 3.6%
- pixantrone
- poly(styrene sulfonate
- polythiazide
- pomalidomide: 0.935% - 35.5%
- ponatinib: 0% - 47%
- posaconazole
- pralatrexate
- pramipexole: common, 3.5% - 14%
- pravastatin: postmarketing, 1.2% - 4%
- prazosin: 3%
- prednisolone phosphate
- prednisone
- pregabalin: postmarketing, 0% - 10.7%
- procarbazine
- prochlorperazine
- progesterone: 2.23% - 3.47%
- promethazine
- propafenone: postmarketing, 0.2% - 11.8%
- propantheline
- propericiazine
- propoxyphene
- propoxyphene napsylate
- propranolol: 1.18% - 3.37%
- prostacyclin
- protriptyline
- quetiapine: 2% - 11%
- quinapril
- quinaprilat
- rabeprazole
- raltegravir
- raltitrexed: 6%
- ramipril
- ramiprilat
- ranitidine
- ranolazine: 4.5% - 7.54%
- rapamycin: 28% - 38%
- rasagiline: common, 4% - 9%
- rasburicase: 20%
- reboxetine: 17.2%
- remifentanil: uncommon, 0% - 19.9%
- repaglinide: 2% - 3%
- rescinnamine: 1.4%
- retigabine: 1% - 5%
- retinoic acid: 17%
- ribavirin: common, 5%
- rifapentine
- rifaximin: 3.75% - 6.43%
- riluzole
- rimantadine
- riociguat: 5%
- risedronate: rare, 2.9% - 12.5%
- risperidone: 1% - 21%
- ritonavir: 0% - 3.4%
- rivaroxaban
- rivastigmine: frequent, 5%
- rizatriptan: infrequent
- rofecoxib
- roflumilast
- ropinirole: frequent, 4% - 6%
- ropivacaine: 0.1% - 4.3%
- rosiglitazone
- rosuvastatin: common, 2.1% - 4.7%
- rotigotine: 6% - 9%
- rufinamide: 3%
- sacrosidase
- salbutamol
- salicylate
- salmeterol
- salmon calcitonin acetate
- saquinavir: common
- scopolamine
- secobarbital
- sertraline: postmarketing, common, 1% - 8%
- sevelamer: postmarketing, 4% - 8%
- sevelamer carbonate: postmarketing, 8%
- sevelamer hydrochloride: postmarketing, 2% - 11.9%
- sibutramine
- sildenafil
- simvastatin: 2.2% - 29.1%
- sitagliptin: postmarketing, uncommon
- sitaxsentan: common, 3.36%
- sodium
- sodium cromoglycate
- sofosbuvir: common
- solifenacin: 5.4% - 13.4%
- sorafenib: postmarketing, 0% - 15%
- sparfloxacin
- stavudine
- strontium ranelate: postmarketing
- sugammadex
- sulindac
- sumatriptan: rare, infrequent
- sunitinib
- tacrolimus: common, 13.6% - 43%
- tadalafil: 4%
- tamoxifen: 4.4% - 8.14%
- tamsulosin: postmarketing, uncommon, 1.3%
- tapentadol: 8% - 17%
- telavancin: common
- telithromycin
- telmisartan: common
- temazepam
- temozolomide: very common, 0% - 32.9%
- temsirolimus
- tenoxicam: common
- terazosin
- tetrabenazine
- tetraen
- thalidomide: 0% - 54.9%
- thiazide
- thioridazine
- thiotepa
- thiothixene
- tiagabine
- tiaprofenic acid: 2.7% - 2.9%
- ticagrelor
- tigecycline: 2.8% - 4.1%
- tinidazole: 0.4% - 1.4%
- tiotropium: 1% - 4%
- tipranavir
- tizanidine: 4%
- tolcapone: 6%
- tolmetin
- tolterodine: 0.7% - 6.6%
- tolvaptan: common, 7.17%
- topiramate: 0% - 7%
- topotecan: very common, 0% - 29%
- torasemide: 1.8%
- toremifene
- trabectedin
- tramadol: common, 9.32% - 46%
- trametinib: 0% - 22%
- trandolapril
- trandolaprilat
- tranylcypromine
- travoprost: rare, uncommon
- trazodone: 7% - 7.92%
- triazolam
- trifluoperazine
- trihexyphenidyl
- trimethoprim: very rare
- trimipramine
- tropicamide
- tropisetron
- trospium chloride: 8.48% - 9.64%
- trovafloxacin
- v 1784: postmarketing
- valdecoxib
- valganciclovir: 8.97% - 20%
- valproate: 5% - 17%
- valsartan
- vandetanib
- varenicline: 5% - 8%
- vemurafenib: postmarketing, 0% - 24%
- venlafaxine: common, 8% - 10%
- verapamil: 2.4% - 11.7%
- verteporfin
- vigabatrin: 3% - 14%
- vildagliptin: uncommon
- vinblastine
- vincristine: 4.82% - 57%
- vinflunine
- vinorelbine: 0% - 35%
- vismodegib: 21%
- vitamin D2
- voriconazole: uncommon
- vorinostat
- zaleplon: frequent
- ziconotide
- zidovudine: 6% - 8.1%
- zidovudine/lamivudine
- zileuton
- ziprasidone: 0% - 9%
- zoledronic acid: uncommon, common, 5% - 23%
- zolmitriptan: rare
- zolpidem: infrequent, 2%
- zonisamide: 2%
- zopiclone
- zuclopenthixol
|
Drugs with this indication
|